• Gynecologic Oncology
• Duke University Medical Center - Gynecologic Oncology
• Harvard, Brigham and Women's Hospital and Massachusetts General Hospital - Obstetrics and Gynecology
• University of Texas Southwestern Medical School - Medicine
Dr. Robert Wenham is a gynecologic oncologist and director of clinical research in The Center for Women’s Oncology at Moffitt Cancer Center.
Dr. Wenham has a strong interest in research and is a principal investigator for the Gynecologic Oncology Group (GOG), the premier national organization developing clinical trials to improve cancer care for women. He is also the principal investigator for the Total Cancer Care Protocol, Moffitt’s unique approach to developing targeted, personalized treatment for each cancer patient. His research activities include the use of novel drugs for the treatment of gynecologic cancers. He has received the Molly Cade Ovarian Cancer Research Award from the Gynecologic Cancer Foundation.
Dr. Wenham enjoys the challenge of helping women with complex issues and the opportunity to offer them cutting-edge therapies, from the latest chemotherapy approaches to biological targeted therapies, minimally invasive surgery and clinical trials. He is also an expert in pelvic exenterative surgery - a very complex operation that offers hope of possible cure for certain patients with gynecologic cancer. Clinically, he prefers a more collaborative approach where the patient plays an active role in decisions as he guides them through the pros and cons of their options.
The future of gynecologic oncology is exciting as the rapid pace of translational research is changing the outcome and quality of life for patients. Dr. Wenham points out that life expectancy for certain women’s cancers, such as ovarian cancer, have dramatically improved over the last 30 years and continue to improve at an encouraging rate.
Dr. Wenham also sees patients at Moffitt Cancer Center at International Plaza.